Literature DB >> 126260

Human chorionic gonadotropin: effects of crude and purified preparations on lymphocyte responses to phytohemagglutinin and allogenenic stimulation.

J L Caldwell, D P Stites, H H Fudenberg.   

Abstract

The factors that prevent maternal immunologic rejection of the histoincompatible fetus are not understood. High levels of human chorionic gonadotropin (HCG) are present in the placenta, and several reports have noted suppresion of mitogen-induced lymphocyte transformation when cultures were supplemented with crude preparations of HCG. Purified HCG and multiple lots of crude HCG obtained from different suppliers were examined for their ability to suppress lymphocyte transformation produced by phytohemallutinin (PHA) or allogeneic stimulation. Crude preparations of HCG produced suppression of the lymphocyte stimulation induced by low doses of PHA, but the suppression could be overcome completely by increasing the PHA dose. The purified preparations of HCG produced no suppression of lymphocyte responses, even at the lower PHA dose. Purified HCG did not give a dose-related suppression of allogeneic lymphocyte responses, and crude lots of HCG gave highly variable results. One lot of crude HCG produced spontaneous stimulation of lymphocytes. Isoelectric focusing of HCG preparations demonstrated multiple bands, and lymphocyte suppression may be secondary to these additional unidentified proteins. The failure of pruified HCG to suppress lymphocyte responses makes it unlikely that the absence of maternal rejection of the fetus is due to high placental levels of HCG.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 126260

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Alteration of the growth of cytomegalovirus and herpes simplex virus type 1 by epidermal growth factor, a contaminant of crude human chorionic gonadotropin preparations.

Authors:  G E Knox; D W Reynolds; S Cohen; C A Alford
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

2.  The effect of preparations of human chorionic gonadotropin on lymphocyte stimulation and immune response.

Authors:  R F Maes; N Claverie
Journal:  Immunology       Date:  1977-09       Impact factor: 7.397

3.  In vitro modulation of lymphocyte responses to phytohaemagglutinin by plasma in mother and baby at the time of birth. Increased lymphocyte responses in babies of mothers with lepromatous leprosy.

Authors:  G Bjune; E Duncan; R S Barnetson; R Melsom
Journal:  Clin Exp Immunol       Date:  1978-06       Impact factor: 4.330

4.  Immunologic and genetic factors influencing reproduction. A review.

Authors:  T J Gill; C F Repetti
Journal:  Am J Pathol       Date:  1979-05       Impact factor: 4.307

5.  In vivo effect of human chorionic gonadotropin on the migration of inflammatory cells in intact or castrated male and female guinea-pigs. A quantitative histological study. I. Study of intact male and female guinea-pigs.

Authors:  R Senelar; J P Bureau
Journal:  Br J Exp Pathol       Date:  1979-10

6.  Are pregnancy-associated serum proteins responsible for the inhibition of lymphocyte transformation by pregnancy serum?

Authors:  W H Stimson
Journal:  Clin Exp Immunol       Date:  1980-04       Impact factor: 4.330

7.  Detection and separation of two serum factors responsible for depression of lymphocyte activity in pregnancy.

Authors:  F M Clarke; H Morton; G J Clunie
Journal:  Clin Exp Immunol       Date:  1978-05       Impact factor: 4.330

8.  A comparison between the composition of maternal peripheral plasma and plasma collected from the retroplacental compartment at caesarean section. A study on protein and steroid hormones and binding proteins.

Authors:  M Norman; C G Eriksson; P Eneroth
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

9.  Human cell-mediated immune responses to chlamydial antigens.

Authors:  L Hanna; L Schmidt; M Sharp; D P Stites; E Jawetz
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

10.  Difference in the placental ferritin levels measured by a specific monoclonal antibody enzymoassay in preterm and term delivery.

Authors:  C Moroz; H Bessler; L Sirota; F Dulitzky; M Djaldetti
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.